Skip to main content

Advertisement

Table 2 Characteristics of the sample (n = 250)

From: Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients

Variable Categories Value
Age   Mean= 54 (sd = 13)
Gender Male 142 (56.8%)
Living alone No 194 (77.6%)
Employed Yes 130 (52.0%)
Education until age 11/12 years 33 (13.2%)
  until age 12/13–14/15 years 118 (47.2%)
  until age 15/16–18/19 years 26 (10.4%)
  advanced (college) 73 (29.2%)
Nationality Swiss 209 (83.6%)
Immunosuppression Cyclosporine & mycophenolate mofetil 71 (28.4%)
  Cyclosporine 38 (15.2%)
  Cyclosporine & azathioprine 37 (14.8%)
  Azathioprine & prednisone 18 (7.2%)
  Azathioprine & tacrolimus 14 (5.6%)
  Other combinations 72 (28.8%)
Monitored immunosuppressives Mycophenolate mofetil 103 (41.2%)
  Cyclosporine 89 (35.6%)
  Azathioprine/prednisone 19 (7.6%)
  Tacrolimus 37 (14.8%)
  Sirolimus 2 (0.8%)
Self-reported EM influence on typical adherence No influence 188 (76.1%)
  Positive influence 53 (21.5%)
  Negative influence 6 (2.4%)